| Diagnosis and management of adult onset Still’s disease P Efthimiou, PK Paik, L Bielory Annals of the rheumatic diseases 65 (5), 564-572, 2006 | 640 | 2006 |
| T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase MW Musch, LL Clarke, D Mamah, LR Gawenis, Z Zhang, W Ellsworth, ... The Journal of clinical investigation 110 (11), 1739-1747, 2002 | 223 | 2002 |
| Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients P Efthimiou, S Schwartzman, LJ Kagen Annals of the rheumatic diseases 65 (9), 1233-1236, 2006 | 190 | 2006 |
| Adult-onset Still's disease—pathogenesis, clinical manifestations, and new treatment options S Kadavath, P Efthimiou Annals of medicine 47 (1), 6-14, 2015 | 180 | 2015 |
| Adult-onset Still’s disease: pathogenesis, clinical manifestations and therapeutic advances A Kontzias, P Efthimiou Drugs 68, 319-337, 2008 | 174 | 2008 |
| Pathogenesis and management of adult-onset Still’s disease P Efthimiou, S Georgy Seminars in arthritis and rheumatism 36 (3), 144-152, 2006 | 168 | 2006 |
| Life-threatening complications of adult-onset Still’s disease P Efthimiou, S Kadavath, B Mehta Clinical rheumatology 33, 305-314, 2014 | 151 | 2014 |
| Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities P Efthimiou, M Kukar Rheumatology international 30, 571-586, 2010 | 145 | 2010 |
| Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis AE Bello, EL Perkins, R Jay, P Efthimiou Open access rheumatology: research and reviews, 67-79, 2017 | 124 | 2017 |
| Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies P Efthimiou, A Kontzias, P Hur, K Rodha, GS Ramakrishna, P Nakasato Seminars in arthritis and rheumatism 51 (4), 858-874, 2021 | 121 | 2021 |
| Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? P Efthimiou, A Kontzias, CM Ward, NS Ogden Nature Clinical Practice Rheumatology 3 (6), 328-335, 2007 | 115 | 2007 |
| The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease A Kontzias, P Efthimiou Seminars in arthritis and rheumatism 42 (2), 201-205, 2012 | 109 | 2012 |
| Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers P Efthimiou, M Blanco Modern rheumatology 19 (5), 457-468, 2009 | 99 | 2009 |
| Ferritin in Adult‐Onset Still’s Disease: Just a Useful Innocent Bystander? B Mehta, P Efthimiou International journal of inflammation 2012 (1), 298405, 2012 | 90 | 2012 |
| IL-1 Trap rilonacept in refractory adult onset Still's disease O Petryna, JJ Cush, P Efthimiou Annals of the rheumatic diseases 71 (12), 2056-2058, 2012 | 77 | 2012 |
| Can traumatic injury trigger psoriatic arthritis? A review of the literature J Hsieh, S Kadavath, P Efthimiou Clinical rheumatology 33, 601-608, 2014 | 76 | 2014 |
| Complementary and alternative medicine in rheumatoid arthritis: no longer the last resort! P Efthimiou, M Kukar, CR MacKenzie HSS Journal® 6 (1), 108-111, 2010 | 73 | 2010 |
| Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups E Feist, P Quartier, B Fautrel, R Schneider, P Sfriso, P Efthimiou, ... Clinical and experimental rheumatology 36 (4), 668-675, 2018 | 72 | 2018 |
| Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs M Kukar, O Petryna, P Efthimiou Biologics: Targets and Therapy, 443-457, 2009 | 64 | 2009 |
| Tumor necrosis factor-α in inflammatory myopathies: pathophysiology and therapeutic implications P Efthimiou Seminars in arthritis and rheumatism 36 (3), 168-172, 2006 | 59 | 2006 |
Bella MehtaHospital for Special Surgery在 hss.edu 的电子邮件经过验证
